MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ARTL — Artelo Biosciences, Inc. Common Stock
NasdaqArtelo Biosciences, Inc. Common Stock
$3.68
-0.15(-3.92%)
- O
- 3.85
- H
- 3.85
- L
- 3.63
- V
- 60.68K
⏱️ End-of-day dataAs of Oct 2, 2026
ARTL — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $10.27M | 600,000.00 | $1.72M | $2.07M | 746,000.00 | $2.34M |
| Other Current Assets | 148,000.00 | 95,000.00 | 107,000.00 | 167,000.00 | 212,000.00 | 219,000.00 |
| Total Current Assets | $10.42M | 695,000.00 | $1.83M | $2.23M | $1.38M | $2.56M |
| Properties | 55,000.00 | 64,000.00 | 73,000.00 | 82,000.00 | 91,000.00 | 99,000.00 |
| Goodwill | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M |
| Intangible Assets | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M | $2.04M |
| Other Non Current Assets | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 |
| Total Non Current Assets | $2.10M | $2.11M | $2.44M | $2.12M | $2.13M | $2.14M |
| Total Assets | $12.52M | $2.80M | $4.27M | $4.36M | $3.52M | $4.70M |
| Accounts Payable | $4.04M | $3.04M | $3.87M | $4.84M | $2.51M | $1.68M |
| Accrued Expenses | 36,000.00 | 15,000.00 | 46,000.00 | 18,000.00 | N/A | N/A |
| Short Term Debt | 701,000.00 | 649,000.00 | 914,000.00 | 827,000.00 | 36,000.00 | 35,000.00 |
| Other Current Liabilities | 582,000.00 | N/A | N/A | N/A | N/A | -3,000.00 |
| Total Current Liabilities | $5.83M | $4.04M | $4.86M | $5.71M | $2.80M | $1.77M |
| Long Term Debt | 18,000.00 | 29,000.00 | 40,000.00 | 51,000.00 | 59,000.00 | 69,000.00 |
| Total Non Current Liabilities | 18,000.00 | 29,000.00 | 40,000.00 | 51,000.00 | 59,000.00 | 69,000.00 |
| Total Liabilities | $5.85M | $4.07M | $4.90M | $5.76M | $2.86M | $1.84M |
| Common Stock | 1,000.00 | 2,000.00 | 2,000.00 | 1,000.00 | 3,000.00 | 3,000.00 |
| Retained Earnings | $-65.97M | $-63.02M | $-58.85M | $-55.73M | $-52.51M | $-50.14M |
| Other Shareholders Equity | -246,000.00 | -272,000.00 | -277,000.00 | -295,000.00 | -227,000.00 | -202,000.00 |
| Total Shareholders Equity | $6.67M | $-1.27M | -633,000.00 | $-1.41M | 652,000.00 | $2.86M |
| Additional Paid In Capital | $72.89M | $62.01M | $58.49M | $54.62M | $53.38M | $53.19M |
| Investments And Advances | N/A | N/A | 325,000.00 | N/A | N/A | N/A |
| Deferred Revenue | N/A | N/A | N/A | N/A | 236,000.00 | N/A |
| Other Short Term Investments | N/A | N/A | N/A | N/A | N/A | 0.00 |